BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22851516)

  • 1. Integrative analysis of cancer prognosis data with multiple subtypes using regularized gradient descent.
    Ma S; Zhang Y; Huang J; Huang Y; Lan Q; Rothman N; Zheng T
    Genet Epidemiol; 2012 Dec; 36(8):829-38. PubMed ID: 22851516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis of prognosis data on multiple cancer subtypes.
    Liu J; Huang J; Zhang Y; Lan Q; Rothman N; Zheng T; Ma S
    Biometrics; 2014 Sep; 70(3):480-8. PubMed ID: 24766212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of non-Hodgkin's lymphoma prognosis signatures using the CTGDR method.
    Ma S; Zhang Y; Huang J; Han X; Holford T; Lan Q; Rothman N; Boyle P; Zheng T
    Bioinformatics; 2010 Jan; 26(1):15-21. PubMed ID: 19850755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of gene-environment interactions in cancer studies using penalization.
    Liu J; Huang J; Zhang Y; Lan Q; Rothman N; Zheng T; Ma S
    Genomics; 2013 Oct; 102(4):189-94. PubMed ID: 23994599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in immune function genes and non-Hodgkin lymphoma survival.
    Aschebrook-Kilfoy B; Zheng T; Foss F; Ma S; Han X; Lan Q; Holford T; Chen Y; Leaderer B; Rothman N; Zhang Y
    J Cancer Surviv; 2012 Mar; 6(1):102-14. PubMed ID: 22113576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
    Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of breast cancer prognosis markers using integrative sparse boosting.
    Ma S; Huang J; Xie Y; Yi N
    Methods Inf Med; 2012; 51(2):152-61. PubMed ID: 22344268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes associated with multiple cancers via integrative analysis.
    Ma S; Huang J; Moran MS
    BMC Genomics; 2009 Nov; 10():535. PubMed ID: 19919702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
    Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
    Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in the DNA repair gene, XRCC1 associate with non-Hodgkin lymphoma susceptibility: A systematic review and meta-analysis.
    Li Y; Bai O; Cui J; Li W
    Eur J Med Genet; 2016 Feb; 59(2):91-103. PubMed ID: 26723520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
    Lan Q; Wang SS; Menashe I; Armstrong B; Zhang Y; Hartge P; Purdue MP; Holford TR; Morton LM; Kricker A; Cerhan JR; Grulich A; Cozen W; Zahm SH; Yeager M; Vajdic CM; Schenk M; Leaderer B; Yuenger J; Severson RK; Chatterjee N; Chanock SJ; Zheng T; Rothman N
    Br J Haematol; 2011 May; 153(3):341-50. PubMed ID: 21418175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma.
    Xie Y; Diao L; Zhang L; Liu C; Xu Z; Liu S
    Gene; 2014 Apr; 539(2):198-202. PubMed ID: 24530479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
    Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
    PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
    Cerhan JR; Novak AJ; Fredericksen ZS; Wang AH; Liebow M; Call TG; Dogan A; Witzig TE; Ansell SM; Habermann TM; Kay NE; Slager SL
    Br J Haematol; 2009 Jun; 145(5):614-23. PubMed ID: 19344414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.
    Bassig BA; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Hu W; Leaderer B; Yeager M; Menashe I; Boyle P; Xu J; Zou K; Zhu Y; Chanock S; Rothman N; Lan Q
    Environ Mol Mutagen; 2012 Mar; 53(2):145-51. PubMed ID: 22170086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
    Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
    Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
    Aya-Bonilla C; Green MR; Camilleri E; Benton M; Keane C; Marlton P; Lea R; Gandhi MK; Griffiths LR
    Genes Chromosomes Cancer; 2013 May; 52(5):467-79. PubMed ID: 23341091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.